News
This leaflet answers some common questions about Cyclosporin Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
Methods We identified all anticoagulant-naive initiators of warfarin, dabigatran, rivaroxaban and apixaban for the indication AF in Norway ... all pharmacies in Norway on dispensations including drug ...
Emilio Parra Doiztua / Bloomberg / Getty Images Pfizer said late Monday that it has agreed to a deal to help develop and market a Chinese cancer drug across the globe. Chinese firm 3SBio is ...
The order applies to "all brand products across all markets that do not currently have generic or biosimilar competition," the HHS said, noting that drug companies must "commit to aligning" their ...
Under a new executive order, prescription drug prices will be reduced “almost immediately.” President Donald Trump, in a May 11 post on Truth Social President Donald Trump expressed high hopes for an ...
chief executive of Switzerland’s Sandoz, said he backed the intention of the administration’s “most favoured nation” policy — where it is seeking to cut prescription drug prices to the ...
100. The Trump administration shared on Tuesday the outlines of how it plans to push pharmaceutical companies to lower their U.S. drug prices to bring them more in line with other nations ...
SPARTANBURG — Earlier this month, federal authorities descended on two Spartanburg County homes executing search warrants and arresting three people in connection to a more than yearlong drugs ...
Many women have, for decades, taken a drug called phenazopyridine to control pain from urinary tract infections. Sold under such brand names as Azo and Uristat, it’s available in most US ...
Peptide-drug conjugates (PDCs) represent an emerging class of targeted therapeutic agents that consist of small molecular drugs coupled to multifunctional peptides through cleavable or non-cleavable ...
Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results